Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.

MLA

Benesch, Martin, et al. “Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.” The Oncologist, vol. 24, no. 9, Sept. 2019, pp. e921–29. EBSCOhost, https://doi.org/10.1634/theoncologist.2018-0489.

APA

Benesch, M., Mynarek, M., Witt, H., Warmuth-Metz, M., Pietsch, T., Bison, B., Pfister, S. M., Pajtler, K. W., Kool, M., Schüller, U., Pietschmann, K., Juhnke, B.-O., Tippelt, S., Fleischhack, G., Schmid, I., Kramm, C. M., Vorwerk, P., Beilken, A., Classen, C. F., … von Hoff, K. (2019). Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series. The Oncologist, 24(9), e921–e929. https://doi.org/10.1634/theoncologist.2018-0489

Chicago

Benesch, Martin, Martin Mynarek, Hendrik Witt, Monika Warmuth-Metz, Torsten Pietsch, Brigitte Bison, Stefan M Pfister, et al. 2019. “Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.” The Oncologist 24 (9): e921–29. doi:10.1634/theoncologist.2018-0489.